iTeos Therapeutics Inc.

iTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.